These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7273760)

  • 21. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of oral contraceptives action on blood folate levels (author's transl)].
    Karlin R; Bourgeay M
    Pathol Biol (Paris); 1976 Apr; 24(4):251-5. PubMed ID: 778757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
    Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 25-hydroxycholecalciferol serum levels in breast-fed infants.
    Ozsoylu S; Hansaoğlu A
    Arch Dis Child; 1981 Apr; 56(4):318. PubMed ID: 7247449
    [No Abstract]   [Full Text] [Related]  

  • 26. Binding specificity of the rat serum vitamin D transport protein.
    Mallon JP; Matuszewski D; Sheppard H
    J Steroid Biochem; 1980 Apr; 13(4):409-13. PubMed ID: 6248687
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum vitamin A and retinol-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
    Mohan Ram M; Bamji MS
    Am J Obstet Gynecol; 1979 Oct; 135(4):470-2. PubMed ID: 573554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women.
    Massa G; Igout A; Rombauts L; Frankenne F; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):569-75. PubMed ID: 8252747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of varying amounts of ethinyl oestradiol in the combined oral contraceptive on plasma sex hormone binding globulin capacity in normal women.
    Pogmore JR; Jequier AM
    Br J Obstet Gynaecol; 1979 Jul; 86(7):563-7. PubMed ID: 573132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteomalacia in presence of "normal" serum 25-hydroxycholecalciferol concentration.
    Kafetz K; Hodkinson HM
    Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1437. PubMed ID: 6797574
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
    Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins (author's transl)].
    Beaumont V; Lemort N; Lorenzelli L; Mosser A; Beaumont JL
    Pathol Biol (Paris); 1978 Dec; 26(9-10):531-7. PubMed ID: 85291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraceptive steroid effects on nonreproductive organ systems.
    Corson SL
    J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives and the cobalamin (vitamin B12) metabolism.
    Hjelt K; Brynskov J; Hippe E; Lundström P; Munck O
    Acta Obstet Gynecol Scand; 1985; 64(1):59-63. PubMed ID: 3976378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of oral steroid contraceptives on fibroadenoma of the breast].
    Prechtel K; Seidel H
    Dtsch Med Wochenschr; 1973 Apr; 98(14):698-702. PubMed ID: 4695395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal folate deficiency and pregnancy wastage. IV. Effects of folic acid supplements, anticonvulsants, and oral contraceptives.
    Pritchard JA; Scott DE; Whalley PJ
    Am J Obstet Gynecol; 1971 Feb; 109(3):341-6. PubMed ID: 5549181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum 25-hydroxycholecalciferol and parathyroid function in the nephrotic syndrome].
    Coen G; Bianchini G; Mazzaferro S; Di Segni M; Bianchi AR; Bravo E; Gallucci G; Cinotti GA
    Minerva Nefrol; 1981; 28(2):133-7. PubMed ID: 7290517
    [No Abstract]   [Full Text] [Related]  

  • 40. Competitive protein binding assay for plasma 25-hydroxycholecalciferol.
    Shimotsuji T; Seino Y
    Methods Enzymol; 1980; 67():466-72. PubMed ID: 6892720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.